Modified Lung Ultrasound Score in Evaluating the Severity of Covid-19 Pneumonia.
Ultrasound Med Biol
; 47(8): 2080-2089, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34088529
Severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (Covid-19), which has been declared as a pandemic by the World Health Organization. The aim of the study described here was to determine the severity of pneumonia and the clinical parameters related to a modified lung ultrasound score (mLUS) in patients with COVID-19 pneumonia. The study included 44 patients with proven COVID-19 pneumonia. Patients were divided into three groups on the basis of pneumonia severity: mild/moderate pneumonia (group I), severe pneumonia (group II) and critically ill patients (group III). It was determined that mLUS values in groups I-III were 6.51 ± 4.12, 23.5 ± 5.9 and 24.7 ± 3.9, respectively. mLUS values were significantly higher in group II and III patients than in group I patients. There was a positive relationship between mLUS and age and N-terminal pro-brain natriuretic peptide level and a negative relationship with PaO2/FiO2 (pâ¯=â¯0.032, ßâ¯=â¯0.275 vs. pâ¯=â¯0.012, ßâ¯=â¯0.315 vs. pâ¯=â¯0.001, ßâ¯=â¯-0.520, respectively). In patients with COVID-19 pneumonia, mLUS increases significantly with the severity of the disease.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ultrasonography
/
SARS-CoV-2
/
COVID-19
/
Lung
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ultrasound Med Biol
Year:
2021
Document type:
Article
Affiliation country:
Turkey
Country of publication:
United kingdom